US 10322168
High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
granted A61KA61K38/28A61K9/0073
Quick answer
US patent 10322168 (High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same) held by Amphastar Pharmaceuticals, Inc. expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Amphastar Pharmaceuticals, Inc.
- Grant date
- Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/28, A61K9/0073, A61K9/008, A61K9/143